CliffBio
small molecule

DIAZOXIDE

DIAZOXIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIAZOXIDE
Active ingredientDIAZOXIDE
Strength50MG/ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2020
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.